Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program

Journal of Managed Care Pharmacy

Volumn 20, Issue 6, 2014, Pages 612-621

  Keast, Shellie L ^a   Thompson, David ^b   Farmer, Kevin ^a   Smith, Michael ^a   Nesser, Nancy ^c   Harrison, Donald ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Oklahoma Health Care Authority   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; ACETIC ACID DERIVATIVE; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIINFECTIVE AGENT; QUINOLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ALLERGIC RHINITIS; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHILD; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRESCRIPTION; TREATMENT OUTCOME; AGE; AMBULATORY CARE; DRUG USE; EMERGENCY HEALTH SERVICE; HEALTH CARE PLANNING; HEALTH INSURANCE; INFANT; INSURANCE; MANAGEMENT; NEWBORN; PRESCHOOL CHILD; PROGRAM EVALUATION; RETROSPECTIVE STUDY; RHINITIS, ALLERGIC; RHINITIS, ALLERGIC, SEASONAL; RISK; STATISTICAL MODEL; TIME; UNITED STATES; ADULT; CLINICAL OUTCOME; CORTICOSTEROID THERAPY; DRUG UTILIZATION; HEALTH CARE POLICY; LONGITUDINAL STUDY; OKLAHOMA;

ACETATES; ADOLESCENT; AGE FACTORS; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ANTI-BACTERIAL AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION REVIEW; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; LINEAR MODELS; LOGISTIC MODELS; MALE; MEDICAID; ODDS RATIO; OFFICE VISITS; POLICY MAKING; PROGRAM EVALUATION; QUINOLINES; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC; RHINITIS, ALLERGIC, SEASONAL; STATE HEALTH PLANS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84901240626     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.6.612     Document Type: Article

References (23)

1. Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Aff (Millwood). 2004;23(1):135-46.
2. Polinski JM, Wang PS, Fischer MA. Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood). 2007;26(3):750-60.
3. U.S. Food and Drug Administration. SINGULAIR label and approval history. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ index.cfm?fuseaction=Search.Overview&DrugName=SINGULAIR. Accessed April 23, 2014.
4. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute (NIH); 2007.
5. Pawankar R, Holgate ST, Canonica GW, Lockey RF, eds. WAO White Book on Allergy. Milwaukee, WI: World Allergy Organization; 2011.
6. Medi-Span. Master Drug Data Base Documentation Manual. Indianapolis, IN: Medi-Span; 2007.
7. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309.
8. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 1973;51(1):95-124.
9. U.S. Census Bureau. Metropolitan and micropolitan statistical areas main. Available at: http://www.census.gov/population/metro/. Accessed April 1, 2014.
10. Boulet LP, Boulay MÈ. Asthma-related comorbidities. Expert Rev Respir Med. 2011;5(3):377-93.
11. Gershon AS, Wang C, Guan J, To T. Burden of comorbidity in individuals with asthma. Thorax. 2010;65(7):612-18.
12. SAS software. Version 9.3. Cary, NC: SAS Institute Inc.
13. Keast SL. Impact of prior authorization of montelukast on resources and outcomes for asthma and allergic rhinitis amongst children and adolescents in a state Medicaid program [dissertation]. Oklahoma City, OK: University of Oklahoma Health Sciences Center; 2013.
14. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clinical Immunol. 2008;122(Suppl 2):S1-S84.
15. Berger WE. Overview of allergic rhinitis. Ann Allergy Asthma Immunol. 2003;90(6 Suppl 3):7-12.
16. Adams AS, Zhang F, LeCates RF, et al. Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Arch Intern Med. 2009;169(8):750-56.
17. Law MR, Ross-Degnan D, Soumerai SB. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. Psychiatr Serv. 2008;59(5):540-46.
18. Fischer MA, Choudhry NK, Winkelmayer WC. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007;26(3):800-07.
19. Kloepfer KM, Helm ME, Perry TT, Hu P, Jones SM, Vargas PA. Preferred drug utilization: treating allergic rhinitis with less-sedating antihistamines. Am J Pharm Benefits. 2012;4(5):e130-e137.
20. Oklahoma Health Care Authority. Minding our P's and Q's: the OHCA SFY 2008 performance and quality report. 2009. Available at: http://www.okhca. org/WorkArea/DownloadAsset.aspx?id=10522. Accessed April 23, 2014.
21. American Lung Association Asthma Clinical Research Centers. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med. 2007;356(20):2027-39.
22. Centers for Disease Control and Prevention. Update: influenza activity- United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep. 20113;60(21):705-12. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6021a5.htm. Accessed April 1, 2014.
23. U.S. Food and Drug Administration. Transition from CFC propelled albuterol inhalers to HFA propelled albuterol inhalers: questions and answers. 2011. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ QuestionsAnswers/ucm077808.htm. Accessed April 1, 2014.